Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Is rising antidepressant prescribing linked to the recession?

Joe Davis takes a closer look at a new study into GP prescribing of antidepressants

A new study claims there may be an association between rising rates of GP prescribing of antidepressants in England and the financial crisis that began in 2008.

The report, Focus On: Antidepressant Prescribing, by the Health Foundation and Nuffield Trust, shows the number of antidepressants dispensed in primary care has risen at a faster rate than at any other point in the past 16 years, with an annual rise of around 8.5% per year after 2008, compared with 6.7% before the recession.

But the authors admitted there was a ‘complex interaction of factors’ driving this increase, and the rise in prescribing across the 16 years could not be linked solely to rising levels of depression.

QOF prevalence figures show only a 0.97 percentage point increase in recorded rates of depression between 2009 to 2012. The report also stated that the strongest indicator for whether a GP practice was more or less likely to prescribe antidepressants was its level of antibiotic prescribing, which the authors said ‘suggests that some GP practices have a higher propensity to prescribe than others’.

The authors also said the rising levels of antidepressant prescriptions could be linked to a change in prescribing patterns among GPs – namely the recent pressures to prescribe smaller quantities of medication at a time.

Cono Ariti, a senior research analyst at the Nuffield Trust says: ‘The jury is still out on the impact of the recession on antidepressant prescribing and the general mental health of the population.

‘To use that well-worn phrase, “more research” and better data are needed to fully understand all of the complexities of the issue.’

He adds: ‘Further research also needs to look at factors on the “supply” side. As we often find, there was wide variation in the prescribing habits of individual GP practices and regional areas.’

 

Data Lowdown-1-Online-infographic

Data Lowdown-2-Online-infographic

 

Data Lowdown-3-Online-July-infographic

Data Lowdown-4-Online-July-infographic

Readers' comments (3)

  • in my experience yes...the current cumbersome inhumane unaccountable incredibly bureaucratic stupid unjust wasteful unhelpful esa pip 'system'..if you can call grossly inefficient chaos a system..definitely has caused a lot of distress misery and i am sure suicides .. i have had many mentally ill patients made worse by damage to self esteem..the 'system' loves to kick people when they are down as it is psychopathic and seems to salivate at causing misery whilst wasting public money to feed its misguided pleasure.

    Unsuitable or offensive? Report this comment

  • This comment has been moderated

  • Are they sure that the increase in Amitryptilline prescribing isn't due to its use in chronic pain, particularly diabetic neuropathy?

    Unsuitable or offensive? Report this comment

  • Oops sorry, should have read the graph properly.

    Unsuitable or offensive? Report this comment

Have your say